Corvus Pharmaceuticals (CRVS) Prepaid Assets (2015 - 2026)
Corvus Pharmaceuticals (CRVS) posted quarterly Prepaid Assets of $367000.0 for Q1 2026, down 69.42% year-over-year from $1.2 million in Q1 2025, and down 38.73% quarter-over-quarter from $599000.0 in Q4 2025.
Corvus Pharmaceuticals (CRVS) Prepaid Assets (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Prepaid Assets history runs 12 years deep, the most recent figure standing at $367000.0 for Q1 2026.
- In Q1 2026, Prepaid Assets fell 69.42% year-over-year to $367000.0; the TTM figure through Mar 2026 stood at $367000.0 (down 69.42% YoY), while the FY2025 annual figure was $599000.0, up 9.31% from the prior year.
- Prepaid Assets for Q1 2026 stood at $367000.0, down from $599000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.2 million in Q3 2024, with the low at $131000.0 in Q1 2023.
- The 5-year median for Prepaid Assets is $548000.0 (2024), against an average of $592764.7.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 503.91% in 2022, then slumped 87.52% in 2023.
- Corvus Pharmaceuticals' Prepaid Assets stood at $773000.0 in 2022, then tumbled by 74.64% to $196000.0 in 2023, then jumped by 179.59% to $548000.0 in 2024, then advanced by 9.31% to $599000.0 in 2025, then tumbled by 38.73% to $367000.0 in 2026.
- Business Quant data shows CRVS's Prepaid Assets at $367000.0 in Q1 2026, $599000.0 in Q4 2025, and $509000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Corvus Pharmaceuticals | 1.25 Bn | 1.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.73 Mn |
| Mar 31, 2026 | 367,000.00 |
| Dec 31, 2025 | 599,000.00 |
| Sep 30, 2025 | 509,000.00 |
| Jun 30, 2025 | 212,000.00 |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 548,000.00 |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 977,000.00 |
| Mar 31, 2024 | 697,000.00 |
| Dec 31, 2023 | 196,000.00 |
| Sep 30, 2023 | 214,000.00 |
| Jun 30, 2023 | 371,000.00 |
| Mar 31, 2023 | 131,000.00 |
| Dec 31, 2022 | 773,000.00 |
| Sep 30, 2022 | 412,000.00 |
| Jun 30, 2022 | 621,000.00 |
| Mar 31, 2022 | 1.05 Mn |
| Dec 31, 2021 | 128,000.00 |
| Sep 30, 2021 | 98,000.00 |